• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 9, Issue 2
  3. Author

Online ISSN: 2515-8260

Volume9, Issue2

Clinically evaluation of the efficacy of post-operative analgesia with epidural bupivacaine with butorphanol, bupivacaine with fentanyl and bupivacaine with nalbuphine

    Dr. Arata Kumar Swain, Dr. Suryasnata Sahoo, Dr. Sabyasachi Das

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 2, Pages 1893-1908

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Background: Pain has already been accepted as the sixth vital sign. Hence, attenuation of pain and alleviation of human suffering is of paramount importance in respect to the service provided by anaesthesiologists, for whom the patients submit a virtual suicidal note in the form of expressed consent. Hence, the importance of the study is self-explanatory.
Objective: The purpose of this study was to clinically evaluate the efficacy of post-operative analgesia with epidural Bupivacaine with Butorphanol, Bupivacaine with Fentanyl and Bupivacaine with Nalbuphine.
Material & Method: 75 patients belonging to ASA Ι and ΙΙ, undergoing lower abdominal surgeries were divided into three groups.
Group A: 0.125% bupivacaine + 2 mg butorphanol.
Group B: 0.125% bupivacaine + 100 mcg. Fentanyl.
Group C: 0.125% bupivacaine + 10 mg Nalbuphine Under all aseptic conditions patients were given epidural block with loss of resistance technique.
Results & Conclusion: Conclusions are drawn from the Study: Opioid analgesics with local anesthetics are extremely safe, effective and reliable method of postoperative pain relief. Fentanyl produces faster onset of analgesia with fewer adverse effects like sedation, pruritus, and nausea and vomiting than butorphanol and nalbuphine when given epidurally along with 0.125% bupivacaine. Butorphanol administered epidurally has advantage of longer duration of analgesia than fentanyl or epidural nalbuphine with side effects like nausea vomiting and sedation.
Keywords:
    Epidural Bupivacaine butorphanol fentannyl
  • PDF (833 K)
  • XML
(2022). Clinically evaluation of the efficacy of post-operative analgesia with epidural bupivacaine with butorphanol, bupivacaine with fentanyl and bupivacaine with nalbuphine. European Journal of Molecular & Clinical Medicine, 9(2), 1893-1908.
Dr. Arata Kumar Swain, Dr. Suryasnata Sahoo, Dr. Sabyasachi Das. "Clinically evaluation of the efficacy of post-operative analgesia with epidural bupivacaine with butorphanol, bupivacaine with fentanyl and bupivacaine with nalbuphine". European Journal of Molecular & Clinical Medicine, 9, 2, 2022, 1893-1908.
(2022). 'Clinically evaluation of the efficacy of post-operative analgesia with epidural bupivacaine with butorphanol, bupivacaine with fentanyl and bupivacaine with nalbuphine', European Journal of Molecular & Clinical Medicine, 9(2), pp. 1893-1908.
Clinically evaluation of the efficacy of post-operative analgesia with epidural bupivacaine with butorphanol, bupivacaine with fentanyl and bupivacaine with nalbuphine. European Journal of Molecular & Clinical Medicine, 2022; 9(2): 1893-1908.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 69
  • PDF Download: 112
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus